Rafferty Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.56M Buy
149,760
+50,655
+51% +$866K 0.01% 546
2025
Q1
$6.32M Sell
99,105
-10,131
-9% -$647K 0.03% 322
2024
Q4
$13.3M Sell
109,236
-28,806
-21% -$3.5M 0.05% 230
2024
Q3
$17.2M Sell
138,042
-8,542
-6% -$1.07M 0.06% 171
2024
Q2
$23.2M Buy
146,584
+72,845
+99% +$11.5M 0.09% 123
2024
Q1
$9.55M Sell
73,739
-29,414
-29% -$3.81M 0.04% 279
2023
Q4
$9.95M Buy
103,153
+28,973
+39% +$2.79M 0.04% 282
2023
Q3
$8.99M Buy
74,180
+9,176
+14% +$1.11M 0.05% 250
2023
Q2
$7.44M Buy
65,004
+16,358
+34% +$1.87M 0.04% 313
2023
Q1
$6.7M Sell
48,646
-21,988
-31% -$3.03M 0.05% 306
2022
Q4
$9.15M Buy
70,634
+9,803
+16% +$1.27M 0.08% 201
2022
Q3
$6.72M Buy
60,831
+504
+0.8% +$55.7K 0.07% 234
2022
Q2
$4.52M Sell
60,327
-13,566
-18% -$1.02M 0.04% 297
2022
Q1
$5.77M Buy
73,893
+7,782
+12% +$608K 0.03% 347
2021
Q4
$5.95M Buy
66,111
+21,752
+49% +$1.96M 0.03% 308
2021
Q3
$4.1M Buy
44,359
+14,027
+46% +$1.3M 0.03% 350
2021
Q2
$2.36M Sell
30,332
-8,192
-21% -$637K 0.01% 639
2021
Q1
$2.87M Buy
38,524
+32,950
+591% +$2.46M 0.02% 521
2020
Q4
$950K Sell
5,574
-9,607
-63% -$1.64M 0.01% 516
2020
Q3
$2.13M Buy
15,181
+9,109
+150% +$1.28M 0.03% 397
2020
Q2
$974K Buy
6,072
+2,482
+69% +$398K 0.01% 555
2020
Q1
$351K Sell
3,590
-26,238
-88% -$2.57M 0.01% 403
2019
Q4
$3.85M Sell
29,828
-45,686
-61% -$5.9M 0.06% 174
2019
Q3
$5.69M Buy
75,514
+34,167
+83% +$2.57M 0.09% 139
2019
Q2
$6.28M Buy
41,347
+3,433
+9% +$522K 0.11% 122
2019
Q1
$4.52M Buy
+37,914
New +$4.52M 0.07% 154